Detalhe da pesquisa
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature;
603(7903): 942-948, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35322232
2.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol;
19(11): 739-752, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36919706
3.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet;
398(10294): 27-40, 2021 07 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34102137
4.
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
N Engl J Med;
373(7): 621-31, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26035255
5.
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.
Br J Haematol;
178(6): 896-905, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28677826
6.
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial.
Hepatology;
60(5): 1697-707, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24996197
7.
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer.
Clin Breast Cancer;
8(3): 234-41, 2008 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18650153
8.
Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies.
Breast;
21(1): 89-94, 2012 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21937232
9.
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
J Clin Oncol;
28(20): 3256-63, 2010 Jul 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20530276
10.
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer.
J Clin Oncol;
25(23): 3399-406, 2007 Aug 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17606975